Group 1: ESG and Green Transition - The central government has systematically deployed a comprehensive green transition for the economy, marking the first top-level design for green low-carbon transformation in China [5] - Central enterprises play a crucial role in the green transition by adjusting industrial structures and upgrading technologies, managing green supply chains, and being assessed on energy conservation and carbon reduction, which accounts for 10% of their performance evaluation [5][6] - Central enterprises are leading in green low-carbon technology innovation, particularly in the fields of new energy technology research and development, process re-engineering, and the construction of new power systems [5] Group 2: Market Performance and Investment Strategy - ESG and central enterprises have shown stable and expanding excess returns since 2024, with ESG and central enterprises yielding better returns compared to the broader A-share market [5] - The valuation of central enterprises is low, with the price-to-earnings ratio at 9.0658, indicating potential investment opportunities [6] - The report suggests an asset allocation strategy that favors monetary assets and increases exposure to overseas assets, as the A-share market has reached a bottom after three months of adjustments [10][11]

行业月报 ·电力设备及新能源行业 风好正扬帆,出海拓新进行时 -8 月行业动态报告 ● 最新观点 全球风电市场前景向好。根据 GWEC 数据,24-28年全球 CAGR 达 9.4%, 其中海风为25%。从装机节奏来看,2/3 新增装机将来自于2028-2033年,其 中 2028年/2032年全球海风新增装机将达到 32.8GW/66.2GW,2024-2028年 CAGR 达 25%, 2028-2033 年 CAGR达 15%。从区域来看,预计欧美 2025年 起量,东南亚等新兴市场 2026年起量。 塔桩龙头顺利出海欧洲。欧洲风电基础单桩主导,单桩本土产能2027年 开始供不应求。欧洲单桩加速大型化,或加深结构性产能瓶颈,国内厂商出海 节奏或将提速,拥有出海码头港口资源以及出海业绩的厂商有望首先受益。大 金重工是亚太区唯一实现海工产品出口欧洲市场的供应商,也是欧洲本土之 外唯一一家能够满足欧洲标准的超大型单桩供应商。天顺风能收购德国工厂, 聚焦单桩,设计产能 50万吨,预计 2025年投产。 欧洲海缆产能紧张,海缆龙头出海顺利。根据 Nexans 公告,其跟踪欧洲 2026-2033 年 建 设 的 ...

行业月报 · 计算机行业 华为全联接大会将召开，信创有望边际回暖 2024年9月4日 ● 8 月板块震荡微跌,板块重点上市公司中报业绩整体承压。人工智能板块 指数(884201.WI)8月涨跌幅为-5.94%,同期上证综指下跌 3.82%, 沪深 300 下跌 3.51%,创业板指数下跌 6.38%,8月板块整体继续维持弱势震荡微跌。 伴随中报业绩披露结束,我们选取人工智能指数中 29 家核心上市公司业绩进 行分析对比,24H1 整体营收端保持强劲增长,利润端短期承压,毛利率出现 下滑趋势,研发仍然维持投入增加。我们认为,24年在宏观基本面偏弱的情 况下,计算机行业在特定行业、领域需求端表现较为疲软,加之研发投入、 人员成本具有一定刚性,导致行业整体在利润端呈现较大压力,下半年建议 关注产业边际变化及重点行业需求端边际回暖。 ● 华为全联接大会召开在即,"纯血鸿蒙"有望大规模商用。2024华为全联 接大会将于华为 9 月 19-21 日,第九届华为全联接大会将在上海举办。本次大 会以"共赢行业智能化"为主题,将举办 300+场主题演讲、峰会、论坛。目 前华为宣布鸿蒙生态设备数量超过9亿台,有超 5000+原生 ...

Investment Rating - The report maintains a "Recommended" rating for the company [3][6]. Core Views - The company reported a slight revenue increase of 1.18% year-on-year for the first half of 2024, with total revenue reaching 5.333 billion yuan and a net profit of 950 million yuan, reflecting a 1.33% increase [1]. - Domestic bidding processes have slowed, impacting short-term performance, while international business continues to grow rapidly, with a 30% year-on-year increase in international revenue [1][2]. - The product mix is improving, contributing to a stable increase in profitability, with a gross margin of 51.01% in Q2 2024, up 3.41 percentage points [1][2]. Summary by Sections Financial Performance - For H1 2024, the company achieved revenues of 5.333 billion yuan, with a net profit of 950 million yuan and a cash flow from operations of -625 million yuan [1]. - Q2 2024 saw revenues of 2.983 billion yuan, a decrease of 2.47%, and a net profit of 587 million yuan, down 3.49% [1]. Domestic and International Markets - Domestic revenue for H1 2024 was 4.401 billion yuan, down 3.35% due to delays in bidding processes and the implementation of large-scale equipment updates [1]. - International revenue reached 933 million yuan, marking a 30% increase year-on-year, with the company expanding its market presence across over 70 countries [1][2]. Product Development and R&D - The company invested 1.017 billion yuan in R&D during H1 2024, an increase of 11.11%, maintaining a leading market share in various product categories [2]. - The company has launched over 120 products to date, with significant market shares in CT and MR products [2]. Profitability and Cost Management - The gross margin improved to 51.01% in Q2 2024, driven by higher service revenue and premium product sales [1][2]. - The company maintained stable expense ratios, with sales, management, and R&D expense ratios at 16.71%, 4.48%, and 15.49%, respectively [1]. Future Outlook - The company is expected to benefit from the recovery of domestic bidding activities and the ongoing expansion of its international business, with projected net profits for 2024-2026 adjusted to 2.296 billion, 2.788 billion, and 3.374 billion yuan, respectively [1][6].

行业月报 · 公用事业行业 风光装机均实现高增长,核电核准数量超预期 — 八月行业动态报告 2024年9月4日 ● 7 月风光装机均实现高增长,全年有望再创新高。7月风电、太阳能新增装 机分别为 4.07GW、21.05GW,同比分别增长 22.6%、12.3%;截至 7月末, 风电、太阳能累计装机 1206GW,同比增长 36.5%,占同期全国累计装机的 38.9%。国网能源研究院在《中国电力供需分析报告 2024》中预计全年风电 新增装机 90GW,同比增长 16.5%;太阳能新增装机在 2023年高基数的基础 上进一步增长,达240GW,同比增长 8.8%,连续两年突破200GW。我国可 再生能源装机在 2023年历史性超过化石能源后,占比将继续提升,装机结构 将持续优化。 ● 7月水电发电量增速回落,火电发电量降幅收窄。7月规上工业火电/水电/ 核电/风电/太阳能发电量分别下降 4.9%/增长 36.2%/增长 4.3%/增长 0.9%/ 增长 16.4%,其中火电增速较 6 月降幅收窄 2.5pct,水电增速较 6 月回落 8.3pct。考虑到去年8月以来来水由枯转丰,预计下半年水电发电量增速将进 ...

行业月报 · 公用事业行业 风光装机均实现高增长,核电核准数量超预期 — 八月行业动态报告 2024年9月4日 ● 7 月风光装机均实现高增长,全年有望再创新高。7月风电、太阳能新增装 机分别为 4.07GW、21.05GW,同比分别增长 22.6%、12.3%;截至 7月末, 风电、太阳能累计装机 1206GW,同比增长 36.5%,占同期全国累计装机的 38.9%。国网能源研究院在《中国电力供需分析报告 2024》中预计全年风电 新增装机 90GW,同比增长 16.5%;太阳能新增装机在 2023年高基数的基础 上进一步增长,达240GW,同比增长 8.8%,连续两年突破200GW。我国可 再生能源装机在 2023年历史性超过化石能源后,占比将继续提升,装机结构 将持续优化。 ● 7月水电发电量增速回落,火电发电量降幅收窄。7月规上工业火电/水电/ 核电/风电/太阳能发电量分别下降 4.9%/增长 36.2%/增长 4.3%/增长 0.9%/ 增长 16.4%,其中火电增速较 6 月降幅收窄 2.5pct,水电增速较 6 月回落 8.3pct。考虑到去年8月以来来水由枯转丰,预计下半年水电发电量增速将进 ...

Investment Rating - The report gives a "Buy" rating for the company, indicating a positive outlook for its future performance [2][30]. Core Insights - The company has entered a phase of rapid development in both research and commercialization, with two leading products, Shuwotini and Golixitinib, having received approval for sale in China [2][30]. - The sales of Shuwotini have shown strong growth, achieving sales revenue of 0.91 billion CNY within four months of its launch and exceeding 2 billion CNY in the first half of 2024, with a growth rate of over 50% for two consecutive quarters [1][12]. - The company is expanding its research team and increasing R&D investment, with R&D expenses reaching 3.83 billion CNY in the first half of 2024, a year-on-year increase of 11.7% [1][12]. - Shuwotini has been included in the CSCO guidelines and is progressing well in global development, with ongoing clinical trials in multiple regions [1][12]. - Golixitinib has also been approved for sale, addressing treatment gaps in PTCL, with a reported ORR of 44% in clinical trials [19][20]. Summary by Sections Financial Performance - In the first half of 2024, the company reported revenue of 2.04 billion CNY, with a net loss of 3.45 billion CNY, narrowing by 32.96% year-on-year [1][12]. - The company expects revenues of 4.51 billion CNY, 9.48 billion CNY, and 16.47 billion CNY for 2024, 2025, and 2026 respectively, with net losses projected at -7.96 billion CNY, -5.16 billion CNY, and -2.94 billion CNY [2][30]. Product Development - Shuwotini is the first approved targeted therapy for EGFR Exon20ins NSCLC, with clinical data showing an ORR of 61% for second-line treatment [15][16]. - Golixitinib is the first high-selectivity JAK1 inhibitor for PTCL, with a CR rate of 24% and a mDoR of 20.7 months in clinical trials [19][20]. Valuation Analysis - The DCF valuation model estimates the company's reasonable market value at 217.48 billion CNY, with a sensitivity range of 188.70 to 255.77 billion CNY [30].

毎日晨报 收敛, 当前估值仍有提升空间。 银河观点集萃 2024年9月5日 | --- | --- | --- | |-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------| | | | | | ● | CGS-NDI 研究：区域经济系列：如何走向城乡融合的 2029?二十届三中全 | 责任编辑 | | | 会明确 ...

公司点评报告 ·建筑行业 绩短期承压，海外新签合同高增长 2024年9月3日 ● ● 事件:公司发布 2024年半年度报告。2024年上半年,公司实现营收 2988.42 亿元,同比下降10.65%;实现归母净利润 41.5亿元,同比下降 42.5%。 业绩短期承压,经营现金流流出增加。2024H1,公司实现营收 2988.42 亿 元,同比下降10.65%,主要是报告期房地产及基建市场调整,工程承包及综合 地产等板块业务收入下降所致;其中,工程承包收入 2773.63 亿元,同比 -10.37%;资源开发收入 32.92 亿元,同比-7.76%;特色业务收入160.31 亿 元,同比-3.14%;综合地产收入50.30亿元,同比-35.39%。公司实现归母净 利润 41.5 亿元,同比下降 42.5%;实现扣非净利润 32.18 亿元,同降 53.9%。 公司实现经营活动现金净流量-284.06亿元,同比多流出 138.9亿元,主要系 业主资金支付周期加长,项目回款速度放缓导致。 ● 减值损失有所增加。2024H1 公司毛利率为 9.05%,同比下降 0.22pct;净利 率为 1.57%,同比下降 1.0 ...

Investment Rating - The report maintains a "Recommended" rating for the company based on the adjustment of profit forecasts and operational performance [2][3]. Core Insights - The company reported a 15.17% year-on-year increase in flight operations, totaling 248,400 flights in H1 2024, which is 103.20% of the 2019 level [3]. - Passenger throughput reached 36.65 million, reflecting a 26.67% year-on-year growth and 102.82% of the 2019 level [3]. - The company achieved a revenue of 3.46 billion yuan in H1 2024, up 19.72% year-on-year, with a net profit attributable to shareholders of 438 million yuan, marking a 204.25% increase [3]. - The company is benefiting from favorable national policies regarding inbound and outbound travel, which is accelerating the recovery of international passenger flow [3]. - The gross margin improved to 27.56% in H1 2024, with operating costs increasing by only 7.44% year-on-year, indicating effective cost control [3]. - The company is progressing with its Phase III expansion project, which includes the construction of new runways and terminals, expected to enhance capacity further [3]. Financial Projections - The company forecasts revenues of 7.25 billion yuan, 8.11 billion yuan, and 9.03 billion yuan for 2024, 2025, and 2026 respectively, with growth rates of 12.76%, 11.78%, and 11.34% [6]. - The projected net profit for 2024 is 919 million yuan, with an expected EPS of 0.39 yuan, and PE ratios of 22.84X for 2024, 19.36X for 2025, and 19.48X for 2026 [6].